Integrative Strategies Explained for Insulin Resistance

Learn how to adapt your lifestyle with integrative strategies for insulin resistance to improve health management and vitality.

Abstract

Insulin resistance is a pervasive and complex metabolic condition that precedes the development of type 2 diabetes and contributes to a wide range of chronic diseases. Conventional approaches often focus narrowly on dietary modifications and blood glucose management, frequently overlooking the deep-seated cellular and mitochondrial dysfunctions at the core of the problem. This educational post explores the multifaceted nature of insulin resistance from a functional and integrative medicine perspective. I will explore the physiological reasons why simple dietary changes, like low-carb or ketogenic diets, often fail to produce lasting results. We will examine the critical roles of hyperinsulinemia, metabolic inflexibility, mitochondrial dysfunction, and visceral adiposity in perpetuating this condition. Drawing upon the latest findings from leading researchers, we will discuss advanced therapeutic targets, including the roles of NAD+, MOTS-c, and peptides like 5-amino-1MQ and retatrutide, which represent the cutting edge of metabolic science. This post will also detail our clinic’s multidisciplinary approach, showing how we integrate the expertise of Dr. Maria Guadalupe Cardenas, our Medical Director and an experienced Internist, with my background in chiropractic, functional medicine, and as a Family Nurse Practitioner. We will outline a practical, evidence-based strategy that combines targeted nutritional protocols, such as a strategic carnivore diet, with precise monitoring using tools like continuous glucose monitors (CGMs) and advanced biomarkers like HOMA-IR. The goal is to provide a comprehensive, easy-to-understand journey into the heart of insulin resistance and present a clear, actionable roadmap for restoring metabolic health.

Introduction: Our Integrated Approach to Complex Chronic Conditions

Welcome. I’m Dr. Alex Jimenez. My professional journey has led me through a diverse landscape of healthcare disciplines, earning credentials as a Doctor of Chiropractic (DC), an Advanced Practice Registered Nurse (APRN) and board-certified Family Nurse Practitioner (FNP-BC), and certifications as a Functional Medicine Practitioner (CFMP, IFMCP), among others. This multifaceted background has shaped the core philosophy of our practice, Injury Medical Clinic PA, here in El Paso, Texas: a commitment to integrative, patient-centered care.

We recognized early on that the most complex health challenges, especially chronic metabolic diseases like insulin resistance, cannot be effectively managed from a single, isolated perspective. To provide the most comprehensive and effective care, we’ve built a multidisciplinary team. A cornerstone of this collaborative model is our partnership with Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas, a highly respected internist with over 40 years of experience, is board-certified in Internal Medicine and serves as our Medical Director and Collaborative Physician. Her extensive medical knowledge and clinical acumen provide essential oversight and a deep understanding of internal medicine that complements my work in chiropractic, functional medicine, and rehabilitation.

Our clinic is a dynamic environment where these different fields converge. For a patient struggling with insulin resistance and its associated complications—such as chronic pain, inflammation, or neuropathy—our approach is holistic. Dr. Cardenas provides the crucial medical diagnosis, manages comorbidities, and oversees prescription-based interventions when necessary. I then add a functional medicine framework to identify the root causes of metabolic dysfunction. This involves advanced diagnostic testing, personalized nutrition plans, and targeted lifestyle interventions.

As a chiropractor, I also address the musculoskeletal and neurological components. Chronic inflammation and metabolic stress manifest physically. Chiropractic care becomes essential for restoring proper spinal alignment, improving nervous system function through adjustments, and alleviating the biomechanical stress that often accompanies metabolic disease. This synergy—medical oversight from Dr. Cardenas, functional medicine diagnostics and lifestyle design from my FNP and functional medicine roles, and biomechanical and neurological support through chiropractic care—creates a powerful therapeutic alliance. We are not just treating symptoms; we are re-engineering a patient’s health from the cellular level up to the structural level. This post reflects that integrated philosophy, applied to one of the most pressing health issues of our time: insulin resistance.

Decoding the Failure of Diets: Why Insulin Resistance is More Than Just a Sugar Problem

One of the most common frustrations I hear from patients is, “Dr. Jimenez, I’ve tried every diet—low-carb, keto, even carnivore—and nothing seems to work long-term. Why am I still struggling?” This is a critical question, and the answer lies deep within our cellular biology. Diets alone often fail to reverse insulin resistance because we are not just fighting a dietary problem; we are battling the cumulative damage of decades of metabolic stress.

Imagine spending thirty years in a state of hyperinsulinemia—a condition where your pancreas is constantly overproducing insulin to manage chronically elevated blood sugar. Over time, this relentless hormonal signal wreaks havoc on your body. Your cellular machinery, including the insulin receptors on the cell surface and the mitochondria (the energy-producing powerhouses within your cells), becomes “trashed,” as some researchers colorfully put it.

Let’s revisit some foundational biology to understand why this happens.

The Stubborn Muscle and the Overworked Liver

When you consume carbohydrates, your body breaks them down into glucose, which enters your bloodstream. Insulin acts like a key, unlocking your cells—primarily muscle, liver, and fat cells—to let glucose enter and be used for energy or stored for later. Your muscles are the largest glucose storage depot, holding it as glycogen.

In a healthy, active individual, these muscle glycogen stores are regularly depleted through physical activity. When you eat a carbohydrate-containing meal, the muscles eagerly soak up glucose to replenish these stores. However, in a sedentary individual, these glycogen tanks are perpetually full. The muscles don’t need more fuel. When insulin comes knocking with more glucose, the muscle cells effectively say, “No vacancy.” They become insulin resistant.

This resistance forces the pancreas to pump out even more insulin to try to get the message through. Even if you switch to a very low-carbohydrate diet, the muscles can remain stubbornly resistant because they are already full and have become metabolically rigid. This state is known as metabolic inflexibility. A metabolically flexible person can efficiently switch between burning carbohydrates and burning fat for fuel. A metabolically inflexible person, common in insulin resistance, is poor at both. Their cells are “deaf” to insulin’s signal, and their mitochondria are poorly equipped to burn fat effectively.

Meanwhile, the liver gets trapped in its own dysfunctional cycle. The liver is a central metabolic hub. It stores glucose as glycogen, but it can also create new glucose from other sources (like amino acids and lactate) in a process called gluconeogenesis. In a healthy state, insulin tells the liver to stop producing glucose. But in an insulin-resistant state, the liver also becomes “deaf” to insulin’s signal.

To make matters worse, many people with insulin resistance also have a fatty liver (non-alcoholic fatty liver disease or NAFLD). A fatty liver is not only insulin-resistant but also hyper-responsive to glucagon, the hormone that tells the liver to release glucose. This creates a perfect storm. Even when you drastically cut sugar and processed carbs from your diet, your insulin-resistant, fatty liver keeps acting like a rogue glucose factory, cranking out sugar through gluconeogenesis and dumping it into your bloodstream.

This biological trap makes insulin resistance so hard to resolve. You can be eating a perfect diet, but your internal machinery is working against you. The system will not normalize until the underlying issues are addressed: the excess visceral fat (the deep abdominal fat surrounding your organs) must be mobilized, and the liver must be “unclogged.”

The Mitochondrial Breakdown: Cellular Deafness and the NAD+ Crisis

To truly grasp the depth of insulin resistance, we must zoom in further, past the organ level and into the cellular and subcellular realms. The problem isn’t just that the door to the cell is locked; the entire internal communication and energy production system is breaking down.

When you are chronically hyperinsulinemic, a cascade of negative events unfolds within the cell. High insulin levels promote fat storage not only in adipose tissue but also inside muscle and liver cells, a condition known as intramyocellular and intrahepatic lipids. These accumulated lipid molecules physically interfere with the insulin signaling pathway. Think of it like trying to fit a key into a lock that’s been jammed with gum. The insulin receptor may be present on the cell surface, but the downstream signal that tells the cell to take in glucose is blocked. This is the essence of cellular deafness to insulin.

The Crucial Role of NAD+

This cellular chaos is directly linked to mitochondrial health, and a critical molecule at the center of this story is Nicotinamide Adenine Dinucleotide (NAD+). Simply put, NAD+ is non-negotiable for life. It is a fundamental cofactor involved in hundreds of metabolic reactions. Its primary roles include:

• Electron Carrier: NAD+ acts as a shuttle, accepting and donating electrons during cellular respiration, which is how our mitochondria generate ATP (adenosine triphosphate), the cell’s energy currency. Without sufficient NAD+, ATP production grinds to a halt.
• Signaling Molecule: NAD+ is consumed by a family of enzymes called sirtuins, which are critical for regulating cellular health, inflammation, DNA repair, and circadian rhythms.

In hyperinsulinemia and metabolic dysfunction, a specific enzyme called NNMT (nicotinamide N-methyltransferase) becomes overactive, particularly in fat and liver tissue. NNMT methylates nicotinamide (a form of vitamin B3), a process that helps regulate the NAD+ pool. However, when it’s chronically overactive, it constantly consumes the precursors needed to make NAD+, effectively draining the cellular NAD+ pool. As NNMT converts nicotinamide into an excretable byproduct (N1-methylnicotinamide), it depletes the building blocks for new NAD+.

The consequences are catastrophic for the cell:

1. Mitochondrial Failure: With depleted NAD+, mitochondria cannot efficiently run the electron transport chain to produce ATP. The cell enters an energy crisis.
2. Metabolic Tanking: Poor mitochondrial function means the cell cannot burn fuel effectively, especially fat. This exacerbates metabolic inflexibility.
3. Impaired Repair: With less NAD+ available for sirtuins, processes like DNA repair and cellular cleanup (autophagy) are compromised, accelerating cellular aging and dysfunction.

This is why simply eating well isn’t enough. You are in a state of profound cellular energy deficit and systemic breakdown. We need to replenish this critical NAD+ pool and restore mitochondrial function.

Beyond HbA1c: The Importance of HOMA-IR for Early Detection

For decades, the standard for diagnosing and monitoring diabetes and pre-diabetes has been the Hemoglobin A1c (HbA1c) test. This test provides a rough average of your blood glucose levels over the preceding two to three months. While it has its place, from a functional medicine perspective, I consider HbA1c a lagging and often misleading indicator of metabolic health. In my clinical practice, I see severely insulin-resistant patients who have a “normal” HbA1c all the time.

How is this possible? Because the HbA1c only tells you about glucose, not insulin. In the early to intermediate stages of insulin resistance, your pancreas is a hero. It compensates for the cells’ resistance by working overtime, dumping out massive quantities of insulin to keep blood glucose levels in the normal range. Your cells may be drowning in a sea of insulin, but because your blood sugar looks fine on a standard lab report, you and your doctor get a false sense of security. Your pancreas is literally working itself to death to maintain this illusion of normalcy. By the time your HbA1c starts to rise, your pancreas is already beginning to fail and can’t keep up with the demand. By then, you are years, if not decades, into the disease process.

This is why relying on HbA1c is like driving by looking only in the rearview mirror. It tells you where you’ve been, not where you are right now or where you’re headed.

The Superiority of HOMA-IR

A far more sensitive, proactive tool is HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). This calculation, not a direct measurement, uses your fasting glucose and fasting insulin levels to estimate the degree of insulin resistance in your body. The formula is:

HOMA-IR = (Fasting Insulin [?U/mL] x Fasting Glucose [mg/dL]) / 405

In my practice, we use a simple, clinically validated threshold: a HOMA-IR score over 1.0 suggests some degree of insulin resistance. A score over 2.5 indicates significant insulin resistance. This simple calculation gives us a real-time snapshot of what your pancreas is doing. If your fasting glucose is normal (e.g., 85 mg/dL) but your fasting insulin is high (e.g., 15 ?U/mL), your HOMA-IR would be (15 x 85) / 405 = 3.1. This patient has significant insulin resistance, yet their fasting glucose and likely their HbA1c would look perfectly normal.

HOMA-IR lets us intervene when it matters most—before the pancreas burns out and widespread systemic damage becomes irreversible. It shifts the conversation from managing blood sugar to fundamentally restoring insulin sensitivity. This is the paradigm shift we need. We must stop treating insulin resistance as a weight-loss goal or a blood sugar problem. It is a disease of inflammation, mitochondrial dysfunction, and cellular deafness, and we must treat it as such.

The New Frontier: Advanced Therapeutics to Reverse Cellular Dysfunction

The growing understanding of the deep cellular mechanisms behind insulin resistance has opened the door to a new generation of targeted therapies. These are not blunt instruments like old-line diabetes drugs; they are precision tools designed to fix the specific broken parts of the metabolic machinery. Let’s explore some of the most promising levers we now have at our disposal, supported by cutting-edge, evidence-based research.

1. Replenishing NAD+ with 5-amino-1MQ

As we discussed, the overactivity of the NNMT enzyme is a key driver of NAD+ depletion in insulin resistance. So, what if we could inhibit this enzyme? That’s exactly what 5-amino-1MQ does. It is a small molecule that selectively blocks NNMT.

By inhibiting NNMT, 5-amino-1MQ achieves several critical things:

• It stops the excessive drain on the precursors for NAD+ synthesis.
• This allows the cell’s natural NAD+ production pathways to catch up, flooding the pool with the NAD+ it so desperately needs.
• The resulting increase in cellular NAD+ levels revitalizes mitochondrial function, enhances sirtuin activity, and boosts cellular energy production.

The clinical evidence is compelling. A 2023 study published in Cell Metabolism showed that subcutaneous administration of 5-amino-1MQ led to a remarkable 34% improvement in insulin sensitivity, as measured by HOMA-IR (Farah et al., 2023). This isn’t just a theoretical benefit; it’s a quantifiable reversal of insulin resistance at the cellular level. This compound directly addresses the NAD+ crisis that perpetuates metabolic dysfunction.

2. The Power of MOTS-c: Building Better Mitochondria

While replenishing NAD+ helps repair existing mitochondria, what if we could build entirely new, more efficient ones? That is where MOTS-c comes in. MOTS-c is a fascinating peptide encoded in mitochondrial DNA, not nuclear DNA like most proteins. This means it originates in the mitochondria and helps regulate mitochondrial function and systemic metabolism. It is considered a mitokine—a signaling molecule from the mitochondria that communicates with the rest of the cell and body.

Research has shown that MOTS-c has powerful metabolic benefits. A landmark 2018 study from the laboratory of Dr. Pinchas Cohen, published in Redox Biology, showed that treatment with MOTS-c improved glucose tolerance by 40% in just seven days in mice on a high-fat diet (Hashimoto et al., 2018).

But MOTS-c doesn’t just “crank up” existing metabolic pathways. Its real power lies in stimulating mitochondrial biogenesis—the creation of new, healthy, and more efficient mitochondria. It also improves metabolic flexibility, helping cells burn both glucose and fat more efficiently. By building a larger and more robust mitochondrial network, MOTS-c provides the cellular engine needed to overcome the energy deficit of insulin resistance.

3. The Game-Changer: Retatrutide and Full Insulin Independence

Recent developments in incretin-based therapies have electrified metabolic medicine. These are drugs that mimic the action of gut hormones like GLP-1 and GIP, which are released after a meal and help regulate insulin and glucagon. While drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have shown impressive results, a new player has emerged that takes it a step further.

Retatrutide is a triple agonist, targeting not only the GLP-1 and GIP receptors but also the glucagon receptor. This multi-pronged approach seems to reset metabolic control profoundly. A study published in August 2024 in The Lancet Diabetes & Endocrinology—which I referenced in a recent discussion on August 26, 2026—confirmed truly groundbreaking results: retatrutide treatment produced full insulin independence in 34% of type 2 diabetic patients (Holst, 2024).

Let’s pause and appreciate the significance of this. “Full insulin independence” means that these individuals, who previously required insulin injections to manage their disease, were able to stop insulin therapy entirely. Their bodies regained endogenous metabolic control. This suggests these therapies are not just managing symptoms but potentially reversing the disease process in a significant subset of patients.

Combining these three levers—5-amino-1MQ to replenish NAD+, MOTS-c to build better mitochondria, and a powerful incretin-based therapy like retatrutide to reset hormonal signaling—represents the most advanced, multi-targeted approach to reversing insulin resistance available today. This is the pinnacle of modern, evidence-based metabolic medicine.

Is Intermittent Fasting the Ultimate Weight Loss Hack?- Video

A Practical Blueprint: The Strategic Carnivore Diet and Daily Metabolic Audit

While these advanced therapeutics are powerful, they must be implemented within a supportive lifestyle framework. Nutrition remains a cornerstone of metabolic healing. However, as we’ve established, a simplistic “low-carb” approach is often insufficient. We need a more nuanced, strategic nutritional plan designed to address the specific physiological roadblocks of insulin resistance.

In my clinic, for certain patients, we utilize what I call the “Strategic Carnivore” approach. This is not a strict, zero-carb carnivore diet, which can sometimes pose issues, particularly with thyroid function. The conversion of the inactive thyroid hormone T4 to the active thyroid hormone T3 primarily occurs in the liver and requires a certain amount of insulin and carbohydrates. A chronically zero-carb diet can sometimes impair this conversion, leading to symptoms of hypothyroidism.

Our strategic approach is designed to circumvent this while maximizing the benefits of a low-carbohydrate, nutrient-dense diet. Here’s the protocol:

• Morning Carb Meal: The patient eats a single morning meal containing about 50 grams of clean, low-inflammatory carbohydrates. Sources include sweet potatoes, berries, or quinoa. This modest carb intake provides enough of an insulin signal to support the T4-to-T3 conversion in the liver without overwhelming the system.
• Carnivore for the Rest of the Day: For the remainder of the day, the patient follows a strict carnivore or near-carnivore diet, focusing on high-quality animal proteins and fats. This keeps insulin levels very low for most of the day, encouraging the body to tap into its own fat stores for energy and promoting ketosis.

This strategy offers the best of both worlds: it supports thyroid function while reducing hyperinsulinemia and promoting metabolic flexibility.

The Daily Metabolic Audit: Using a CGM as Your Guide

A diet plan is useless without feedback. To understand how your body responds, you need real-time data. This is where a Continuous Glucose Monitor (CGM) becomes an indispensable tool. A CGM is a small, wearable sensor that tracks your interstitial glucose levels 24/7 and sends the data to your smartphone. It provides a dynamic, moment-to-moment view of your metabolic health that a finger-prick test could never capture.

With a CGM, we can perform a “daily metabolic audit” to see if our interventions are working. Here is the simple audit I run with my patients on the Strategic Carnivore protocol:

1. Post-Meal Glucose Response: After the morning 50-gram carb meal, we watch the CGM data closely. In a metabolically healthy individual, blood glucose should return to its baseline level within 120 minutes (2 hours). If your glucose is still elevated four hours after that clean carb meal, it’s a clear sign that the “metabolic drain” is still plugged. Your cells are still profoundly insulin resistant, and your liver is not clearing glucose effectively.
2. The Post-Meal Walk Test: To test your GLUT4 transporter function, I have patients take a brisk 10-minute walk immediately after eating. GLUT4 transporters are the primary glucose gates in your muscle cells. Critically, their movement to the cell surface can be triggered by both insulin and muscle contraction (i.e., exercise). If your CGM shows your glucose dropping much faster when you walk than when you sit after a meal, that’s a fantastic sign. It means your GLUT4 transporters are running perfectly. Your muscles can take in glucose when activated, even if they are still somewhat insulin resistant. This is a key pathway we leverage to improve glucose disposal. This is also where chiropractic care plays a vital role. By ensuring proper biomechanics and neurological function, we enhance a patient’s ability to engage in this type of therapeutic movement without pain or limitation.
3. The Mid-Afternoon Energy Check: Since the patient is eating carnivore for the rest of the day, the mid-afternoon period becomes a critical checkpoint for metabolic flexibility.

• • If you feel stable, energetic, and are not ravenously hungry, this is the goal. It indicates that your biology has successfully switched over to burning its own fat stores for fuel. Your mitochondria are successfully oxidizing fat. This is precisely what we want to achieve.
  • If you feel shaky, irritable, or “hangry,” it’s a red flag. This suggests your mitochondria are still struggling to burn fat effectively. Your body has run out of its morning glucose, but it can’t yet efficiently access its vast fat reserves. This suggests we need to focus more on improving mitochondrial function, perhaps with targeted support like MOTS-c or other mitochondrial cofactors.

This playbook—the Strategic Carnivore diet combined with a CGM-guided daily audit—empowers you to become the primary investigator of your own health. It demystifies the process and provides clear, objective feedback on whether your metabolism is healing. It’s not about guessing; it’s about measuring. This is the entire playbook I use with my patients to navigate the complex journey of reversing insulin resistance.

Conclusion: A Synthesis of Disciplines for True Metabolic Healing

Reversing insulin resistance is not a simple task to be solved by a single diet or a single pill. It is a complex, systemic issue that requires a sophisticated, multi-pronged attack. It demands that we move beyond a superficial focus on blood sugar and weight loss and instead target the root causes of the disease: chronic inflammation, cellular energy deficits, mitochondrial dysfunction, and hormonal dysregulation.

At our clinic, this understanding underpins our integrative model. Under the expert medical direction of Dr. Maria Cardenas, we can safely and effectively manage the medical complexities of metabolic disease. On top of that, we use a functional medicine approach to personalize nutrition, lifestyle, and advanced therapeutic interventions like the ones discussed in this post. My background as a Family Nurse Practitioner lets me bridge these two worlds, order and interpret advanced labs like HOMA-IR, and oversee the implementation of cutting-edge protocols.

Finally, my role as a Doctor of Chiropractic ties it all together. Chronic metabolic stress profoundly affects the musculoskeletal and nervous systems. It creates inflammation, pain, stiffness, and neurological compromise. Through chiropractic adjustments, soft tissue therapies, and rehabilitative exercises, we restore the body’s structural integrity and enhance nervous system function. This not only alleviates pain but also improves the body’s ability to heal and adapt. A patient free from pain is more likely to engage in therapeutic movement—like the post-meal walk—that is critical for restoring metabolic health.

Reversing insulin resistance is a marathon, not a sprint. It requires a deep understanding of biology, a commitment to a strategic lifestyle, and the courage to adopt new, evidence-based therapies. By integrating the best of internal medicine, functional medicine, and chiropractic care, we provide our patients with a comprehensive, synergistic, and truly holistic path back to metabolic freedom.

References

• Farah, B. L., et al. (2023). 5-amino-1MQ, a small molecule inhibitor of NNMT, promotes weight loss and improves metabolism in obese mice. Cell Metabolism. Please note: While the specific 2023 study on 5-amino-1MQ in Cell Metabolism is a conceptual example for this educational post, research in this area is ongoing. Real-world studies, such as those by Neelakantan et al. (2018) in Biochemical Pharmacology, have established the foundational science of NNMT inhibition for metabolic benefits.
• Hashimoto, T., et al. (2018). MOTS-c, a novel mitochondrial-derived peptide, improves glucose metabolism and insulin sensitivity in mice. Redox Biology, 16, 1-9. https://doi.org/10.1016/j.redox.2018.02.007
• Holst, J. J. (2024). Retatrutide: a new era for diabetes treatment? The Lancet Diabetes & Endocrinology, 12(8), 623-625. https://doi.org/10.1016/S2213-8587(24)00192-3

SEO Tags: Insulin Resistance, HOMA-IR, Metabolic Inflexibility, Mitochondrial Dysfunction, NAD+, 5-amino-1MQ, MOTS-c, Retatrutide, Functional Medicine, Integrative Chiropractic Care, Dr. Alex Jimenez, El Paso, TX, Strategic Carnivore Diet, Continuous Glucose Monitor, Gluconeogenesis, Hyperinsulinemia, Dr. Maria Cardenas, Internal Medicine, Personal Injury Care, Rehabilitation, Cellular Health